Journal: bioRxiv
Article Title: Nup358 Sustains Intestinal Epithelial Homeostasis by Preventing Dvl1 Condensate Formation to Restrain Wnt Signaling
doi: 10.64898/2026.03.25.714063
Figure Lengend Snippet: a. Quantification of body weight in Nup358 fl/fl and Nup358 fl/fl CreER T 2 mice treated with tamoxifen. Data are expressed as mean ± SD. ****p ≤ 0.0001. b. Small intestine length in Nup358 fl/fl and Nup358 fl/fl CreER T2 mice treated with tamoxifen. Data are expressed as mean ± SD. *p ≤ 0.05. c. Duodenum cross-sectional area in Nup358 fl/fl and Nup358 fl/fl CreER T2 mice treated with tamoxifen. Data are expressed as mean ± SD. **p ≤ 0.01. d. Representative images of hematoxylin and eosin stained small intestine section from Nup358 fl/fl and Nup358 fl/fl CreER T 2 mice treated with tamoxifen. Color boxes marked the zoom-in regions of crypt and villi. e. Immunofluorescence staining for Nup358 in small intestinal epithelium from Nup358 fl/fl and Nup358 fl/fl CreER T 2 mice treated with tamoxifen. f. Immunofluorescence staining for CD44, Ki67, and activated caspase 3 in small intestinal epithelium from Nup358 fl/fl and Nup358 fl/fl CreER T 2 mice treated with tamoxifen. Bottom: Quantification of immunofluorescence intensity per area for CD44, Ki67, and activated caspase 3.
Article Snippet: Antibodies used for immunofluorescence and immunoblotting are as follows: anti-Ki67 (Biolegend, #151206), anti-Nup358/RanBP2 (Bethyl Laboratories, A301-796A), anti-Nup358 (Santa Cruz Biotechnology, sc74518), anti-CD44 (Biolegend, #103012), Anti-activated Caspase 3 (CST #9664). anti-Olfm4 (CST # 39141), anti-TCF-4/TCF7L2 (CST, #2569), anti-Dvl1 (Santa Cruz, #sc8025), anti-Axin1 (CST, #2087), anti-α-Tubulin (CST, #3873), anti-ADP-Ribosylation (CST, #891990), anti-ADP-Ribosylation (CST, #89190), anti-HA (CST, #3724), anti-Histone 3 (CST # 9715), anti-Ubc9 (Abcam, ab33044), anti-Nup98 (Cell Signaling Technology, 2598P), anti-GAPDH (CST, #5174), and anti-GFP (Abcam, #1218).
Techniques: Staining, Immunofluorescence